Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Amneal Pharmaceuticals Inc (AMRX)
NYSE:AMRX
Amneal Pharmaceuticals (AMRX) Stock Price & Analysis
323 Followers
AMRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.24 - $3.77
Previous Close$2.39
Volume3.12M
Average Volume (3M)958.69K
Market Cap
$730.04M
Enterprise Value$3.18B
Total Cash (Recent Filing)$151.07M
Total Debt (Recent Filing)$2.73B
Price to Earnings (P/E)-2.7
Beta1.28
Next Earnings
Aug 10, 2023EPS Estimate
$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.89
Shares Outstanding305,454,163
10 Day Avg. Volume986,673
30 Day Avg. Volume958,689
Standard Deviation0.18
R-Squared0.17
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.40
Enterprise Value/Gross Profit4.05
Enterprise Value/Ebitda18.54
Forecast
1Y Price Target
$3.60Price Target Upside53.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Amneal Pharmaceuticals News
Pre-EarningsAmneal Pharma (AMRX) Q1 Earnings Cheat Sheet
Market NewsAmeal Soars on Promising Q1 Prelim Numbers
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMRX FAQ
What was Amneal Pharmaceuticals Inc’s price range in the past 12 months?
Amneal Pharmaceuticals Inc lowest stock price was $1.24 and its highest was $3.77 in the past 12 months.
What is Amneal Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Amneal Pharmaceuticals Inc’s upcoming earnings report date?
Amneal Pharmaceuticals Inc’s upcoming earnings report date is Aug 10, 2023 which is in 70 days.
How were Amneal Pharmaceuticals Inc’s earnings last quarter?
Amneal Pharmaceuticals Inc released its earnings results on May 05, 2023. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.096 by $0.024.
Is Amneal Pharmaceuticals Inc overvalued?
According to Wall Street analysts Amneal Pharmaceuticals Inc’s price is currently Undervalued.
Does Amneal Pharmaceuticals Inc pay dividends?
Amneal Pharmaceuticals Inc does not currently pay dividends.
What is Amneal Pharmaceuticals Inc’s EPS estimate?
Amneal Pharmaceuticals Inc’s EPS estimate is $0.11.
How many shares outstanding does Amneal Pharmaceuticals Inc have?
Amneal Pharmaceuticals Inc has 153,337,280 shares outstanding.
What happened to Amneal Pharmaceuticals Inc’s price movement after its last earnings report?
Amneal Pharmaceuticals Inc reported an EPS of $0.12 in its last earnings report, beating expectations of $0.096. Following the earnings report the stock price went up 4.348%.
Which hedge fund is a major shareholder of Amneal Pharmaceuticals Inc?
Among the largest hedge funds holding Amneal Pharmaceuticals Inc’s share is Hussman Strategic Advisors Inc. It holds Amneal Pharmaceuticals Inc’s shares valued at 250K.
---
Amneal Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.60 (53.85% Upside)
$3.60 (53.85% Upside)
Blogger Sentiment
Bullish
AMRX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 513.8K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.92%
12-Months-Change
Fundamentals
Return on Equity
-39.32%
Trailing 12-Months
Asset Growth
-6.75%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.
---
Top 5 ETFs holding AMRX
Vanguard Total Stock Market ETF
$7.70M
Vanguard Health Care ETF
$644.02K
iShares Russell 3000 ETF
$129.84K
Schwab U.S. Broad Market ETF
$129.62K
Fidelity MSCI Health Care Index ETF
$119.43K
Up to five ETFs with an Outperform Smart Score that hold AMRX. The ETFs are listed according to market value of AMRX within the ETF
---
---